| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |